deferoxamine has been researched along with Depressive Disorder in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Réus, GZ | 1 |
| Dos Santos, MA | 1 |
| Abelaira, HM | 1 |
| Titus, SE | 1 |
| Carlessi, AS | 1 |
| Matias, BI | 1 |
| Bruchchen, L | 1 |
| Florentino, D | 1 |
| Vieira, A | 1 |
| Petronilho, F | 1 |
| Ceretta, LB | 1 |
| Zugno, AI | 1 |
| Quevedo, J | 1 |
| Cutler, P | 1 |
2 other studies available for deferoxamine and Depressive Disorder
| Article | Year |
|---|---|
Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas.
Topics: Acetylcysteine; Animals; Antioxidants; Behavior, Animal; Brain; Deferoxamine; Depressive Disorder; D | 2016 |
Iron overload and psychiatric illness.
Topics: Adult; Aged; Anxiety Disorders; Carrier Proteins; Deferoxamine; Dementia; Depressive Disorder; Diagn | 1994 |